COLE, SCOTT – Trademark Portfolio

Entity Type: 01

COLE, SCOTT holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. The owner is based in CAREFREE, AZ.

P.O. BOX 1357

CAREFREE, AZ 85377

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

COLE, SCOTT's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does COLE, SCOTT have?

COLE, SCOTT has 6 U.S. trademarks filed with the USPTO.

What trademark classes does COLE, SCOTT file in?

COLE, SCOTT files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is COLE, SCOTT's trademark registration success rate?

COLE, SCOTT has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.